The invention relates to a compound, and pharmaceutically acceptable salts, having
the formula I:
##STR1##
wherein:
- R represents an alkyl or alkynyl group having 1-4 carbon atoms, or a
phenyl group optionally substituted by C1-4 alkyl, alkylthio, alkoxy,
halogen, nitro, acylamino, methylsulfonyl or methylenedioxy, or represents tetrahydronaphthyl,
- R1 represents hydrogen, trifluoro (C1-4) alkyl,
alkyl or alkynyl,
- X represents hydrogen, alkyl having 1-4 carbon atoms, alkoxy, trifluoroalkyl,
hydroxy, halogen, methylthio or aralkoxy,
- R2 represents:
- a C1-C10 alkyl group,
- a phenyl group optionally substituted by one or more of the following groups:
- a C1-C10 alkyl group,
- a halogen group,
- a nitro group,
- hydroxy group,
- and/or an alkoxy group.
|
|
|